Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does preserving memory correlate with surviving HIV?

Helen Horton1, Stephen C De Rosa

  • 1Program in Infectious Diseases, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, WA 98109, USA.

Trends in Microbiology
|November 23, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase 1 randomized controlled trial to evaluate the safety and immunogenicity of a HIV monomeric gp120 protein B-cell lineage targeting HIV vaccine in healthy adults.

medRxiv : the preprint server for health sciences·2026
Same author

Menstruation is associated with cyclical granulysin peaks in vaginal secretions despite stable expression by cervicovaginal immune cells.

bioRxiv : the preprint server for biology·2026
Same author

Coordinated immune response distinguishes duration of SARS-CoV-2 viral particle shedding in humans.

iScience·2026
Same author

DNA electroporation of HIV Env elicits robust T cell responses and memory B cell responses with muted serum antibody levels that can be boosted with recombinant protein.

Vaccine·2026
Same author

The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adults.

Vaccine·2026
Same author

Potent and dose-sparing next-generation SARS-CoV-2 vaccine, mRNA-1283, induces polyfunctional and durable T cell immunity.

NPJ vaccines·2026
Same journal

Environmental microbes as modulators of plant volatile landscapes: Implications for plant-insect chemical communication.

Trends in microbiology·2026
Same journal

Beyond AMGs: Phage-encoded transcription and sigma factors as understudied virocell reprogramming tools.

Trends in microbiology·2026
Same journal

Cronobacter spp.

Trends in microbiology·2026
Same journal

Anaerobic lignin deconstruction: A game changer for lignocellulosic biorefineries.

Trends in microbiology·2026
Same journal

Critical role of the inflammatory rheostat in influenza-associated pulmonary aspergillosis.

Trends in microbiology·2026
Same journal

Structure-based prokaryotic transcription shapes adaptation and host-invader interplay.

Trends in microbiology·2026
See all related articles

Developing an effective HIV vaccine is crucial. New research identifies preserving memory CD4(+) T cells during infection as a key survival marker after simian immunodeficiency virus (SIV) exposure.

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Developing an effective human immunodeficiency virus (HIV) vaccine remains a significant global health challenge.
  • Identifying correlates of protection is essential for advancing vaccine development.
  • Previous research has focused on various immune responses as potential correlates.

Purpose of the Study:

  • To highlight the significance of recent findings defining a correlate of survival following simian immunodeficiency virus (SIV) infection.
  • To discuss the implications of this correlate for HIV-1 vaccine research.
  • To identify critical issues for translating this correlate to human clinical trials.

Main Methods:

  • Analysis of two recent research papers.
  • Review of data on SIV infection and vaccination outcomes in animal models.

Related Experiment Videos

  • Discussion of immunological principles related to T cell memory and viral control.

    • Main Results:

    • A correlate of survival following SIV infection has been defined: preservation of memory CD4(+) T cells during acute infection.
    • Vaccination strategies can prevent initial immune damage caused by SIV infection.
    • This preservation of CD4(+) T cells correlates with improved survival after SIV challenge.

    Conclusions:

    • The definition of a correlate of survival in SIV infection represents a step forward in HIV-1 vaccine research.
    • This finding offers a potential new avenue for evaluating vaccine efficacy.
    • Further research is needed to address crucial issues before applying this correlate in human HIV vaccine trials.